ArticleInternal medicine (Tokyo, Japan)2022

Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS.

Eisuke Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.